Xencor Inc (XNCR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.55
• Market Cap: $855.50M
• EPS: $-1.75
• 52-Week High: $18.69
• 52-Week Low: $6.92

Market Sentiment

Xencor Inc currently has a Neutral sentiment score of -0.03.

About Xencor Inc

Xencor, Inc. is a clinical-stage biopharmaceutical company based in Monrovia, California, focused on the development of advanced cytokine and monoclonal antibody therapies targeting unmet medical needs in oncology and autoimmune disorders. Utilizing its proprietary XmAb technology platform, Xencor aims to improve therapeutic efficacy and safety, offering promising solutions to complex health challenges. With a strong and diverse pipeline poised for clinical advancement, Xencor is well-positio...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Xencor Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XNCR pay dividends?

Xencor Inc (XNCR) does not currently pay a regular dividend.

What is XNCR's market cap?

Xencor Inc (XNCR) has a market capitalization of $855.50M with a current stock price of $13.55.